Wegovy Shortage 2026: Where to Get It Now

Introduction

The Wegovy® shortage that began in 2022 was officially declared resolved by the FDA in February 2025. But “resolved” on paper and “easy to fill at your local CVS” are different things. In 2026, intermittent backorders at specific pen strengths still happen, and patients are still calling 12 pharmacies to find one strength in stock.

Novo Nordisk has spent more than $6 billion expanding manufacturing capacity since 2022, including the Catalent acquisition completed in late 2024 and new fill-finish lines in North Carolina and Denmark. Production is up, demand is up more. This piece covers what the shortage looks like in 2026, what’s actually available, and where to go when your pharmacy says no.

At TrimRx, we believe that understanding your options is the first step toward a more manageable health journey. You can take the free assessment quiz if you’re ready to see whether a personalized program is a fit for you.

Is Wegovy Still in Shortage in 2026?

No, not officially. The FDA Drug Shortage Database declared the Wegovy shortage resolved on February 21, 2025, after Novo Nordisk’s manufacturing capacity caught up with U.S. demand. That ended the legal basis for 503B outsourcing facilities to mass-produce semaglutide copies under the FDA’s shortage exception.

Quick Answer: FDA removed Wegovy from the official shortage list in February 2025, but pharmacy-level supply remains uneven for specific strengths

In practice, individual pharmacies still report stock gaps. A Trilliant Health pharmacy survey in early 2026 found that 31% of independent pharmacies and 18% of chain locations had at least one Wegovy strength out of stock on a given week. The 1.7 mg titration dose and 2.4 mg maintenance dose move slowest through the supply chain, partly because those are the doses most patients stay on long-term.

Novo Nordisk now ships roughly 4.5 million Wegovy pens per month into the U.S. market, up from 1.2 million in mid-2023. Demand has grown alongside that. SELECT trial results (Lincoff et al. 2023 NEJM) showing 20% MACE reduction expanded the eligible population by tens of millions overnight.

Which Wegovy Strengths Are Easiest to Find?

The starter strengths, 0.25 mg and 0.5 mg, are the most available in 2026. Novo Nordisk explicitly prioritized titration doses to keep new patients moving through onboarding without disruption. If you’re starting therapy now, you’re unlikely to hit a wall in the first 8 weeks.

The middle strengths, 1.0 mg and 1.7 mg, see periodic gaps of 1 to 3 weeks. The 2.4 mg maintenance dose is the bottleneck. It’s the dose used by the bulk of patients who completed titration and is also the dose studied in STEP 1 (Wilding et al. 2021 NEJM) where 14.9% mean weight loss was reported at 68 weeks.

If your pharmacy can’t fill 2.4 mg, ask whether they can dispense two 1.7 mg pens to bridge a few weeks. Some prescribers will write for that. Some won’t. Don’t change your own dosing without your prescriber agreeing.

What Is Causing the Residual Shortage?

Three things. First, semaglutide is a 31-amino-acid peptide that requires solid-phase synthesis followed by complex purification, and global capacity for that chemistry is finite. Novo Nordisk paid $16.5 billion in 2024 to acquire Catalent partly to lock up fill-finish capacity at three plants.

Second, the SELECT cardiovascular indication approved in March 2024 dramatically widened the prescription pool. Patients with established cardiovascular disease and a BMI over 27 became eligible for the brand-labeled cardiovascular indication, not just obesity treatment.

Third, off-label demand for cosmetic weight loss in patients with BMI 25 to 27 keeps pulling supply out of the system. Novo doesn’t market for that use, but prescribers write it. Some payers cover it. The net effect is more pens leaving the warehouse than predicted.

What Is the NovoCare DiRECT Program?

NovoCare Pharmacy is Novo Nordisk’s direct-to-patient channel launched in March 2025. It ships Wegovy directly to cash-pay patients at $499 per month for any approved strength, with prescription verification handled through the company’s portal. The price is roughly a third of the typical retail list price.

The catch is eligibility. NovoCare is meant for patients without insurance coverage for Wegovy, so if your insurer covers any portion of the drug, you generally can’t use NovoCare. The program also requires a U.S. prescription from a licensed prescriber and verifies identity through a portal that has had reliability complaints in user forums.

For uninsured or fully cash-pay patients, NovoCare cuts the list price meaningfully. It also keeps you inside the brand-name supply chain, which matters if your prescriber needs to document brand-product use for an insurance appeal later.

Is Compounded Semaglutide Still Legal in 2026?

Yes, but in a narrower way than it was in 2024. The FDA’s shortage exception under section 503B that allowed outsourcing facilities to mass-produce semaglutide ended on May 22, 2025. After that date, 503B facilities can no longer make copies of FDA-approved semaglutide formulations.

State-licensed 503A pharmacies can still compound semaglutide when the prescriber documents a clinical reason the commercial product won’t work. Examples include allergies to inactive ingredients, the need for a different dose strength than commercial pens offer, or the need for a combination product. The bar is higher than it was, but it’s not closed.

TrimRx works with licensed compounding pharmacies that follow current FDA guidance on personalized compounding. The free assessment quiz screens whether your situation supports a clinical case for compounding versus a commercial Wegovy prescription.

Key Takeaway: Novo Nordisk’s NovoCare direct-to-patient program offers cash pay around $499 per month for all strengths

How Do I Find Wegovy in Stock Near Me?

Use the Wegovy Stock Locator tool on wegovy.com first. Novo Nordisk updates pharmacy inventory data through their CoverMyMeds integration and refreshes the locator every few hours. The tool is honest about which strengths are missing where.

Then call before you drive. Pharmacy stock changes hourly. A pharmacy that showed green on the locator two hours ago may have filled three scripts since. Independent pharmacies often have better access than chains in 2026 because they can order directly from wholesalers like Cardinal and AmerisourceBergen without going through a corporate allocation gate.

Mail-order pharmacies tied to insurance plans, like Express Scripts and OptumRx, generally have steadier supply than retail pharmacies. If your plan offers 90-day mail-order, switching to that channel is the single most reliable move you can make in 2026.

What If My Pharmacy Keeps Saying It’s on Backorder?

Backorder language has specific meanings. “On allocation” means the pharmacy can order but the wholesaler is rationing. “Manufacturer backorder” means Novo Nordisk’s distribution center can’t ship to wholesalers right now. “Indefinite” means there’s no resolution date.

Ask the pharmacy which of those three categories applies and ask for the wholesaler’s expected restock date. They have it. Many techs won’t volunteer it unless asked. If the answer is more than 2 weeks out, ask your prescriber for a one-time switch to a different strength you can find, or a temporary prescription for tirzepatide if clinically appropriate.

Document every refused fill in writing. If you later need to appeal an insurance denial that says “should have stayed on Wegovy,” that documentation matters.

Can I Switch to Zepbound® During the Wegovy Shortage?

Often yes, with prescriber approval. Zepbound (tirzepatide) is a different drug with a different mechanism, dual GIP and GLP-1 agonism versus semaglutide’s GLP-1-only action. SURMOUNT-1 (Jastreboff et al. 2022 NEJM) reported 20.9% mean weight loss at 72 weeks, higher than the 14.9% seen in STEP 1 with semaglutide.

Switching requires a new prescription and usually a new prior authorization. Insurance plans treat the two as separate drugs even though both target obesity. Some plans require failure on one before approving the other. Others let you pick.

Clinically, restart titration at the lowest dose when switching. Don’t assume the dose you were taking maps over. Tirzepatide’s side effect profile is similar but timing differs, and your gut needs the same slow ramp it had on semaglutide.

What About Ozempic® During the Wegovy Shortage?

Ozempic is the same molecule as Wegovy, semaglutide, but FDA-approved for type 2 diabetes at different dose strengths (0.25 mg, 0.5 mg, 1.0 mg, 2.0 mg). Prescribing Ozempic off-label for obesity was common during the 2022 to 2024 shortage and is now contested.

Some prescribers still do it. Insurance generally won’t pay for Ozempic off-label, and Novo Nordisk has lobbied prescribers and pharmacies to keep Ozempic available for diabetes patients. If your prescriber writes Ozempic off-label for weight loss in 2026, expect to pay cash, expect questions from the pharmacy, and expect that NovoCare won’t help with off-label use.

The 2.0 mg Ozempic strength is the closest practical equivalent to 2.4 mg Wegovy. It’s not the same. The clinical trials supporting Wegovy’s obesity indication used 2.4 mg specifically.

Bottom line: Personalized compounded semaglutide remains available through state-licensed pharmacies when clinically justified

FAQ

Is the FDA Shortage List Updated in Real Time?

Roughly weekly. The FDA’s Drug Shortage Database lists current shortages and resolution dates, but pharmacy-level supply lags by days to weeks. Always cross-check with the manufacturer’s locator tool and a call to your pharmacy.

Can I Get Wegovy From a Canadian or Mexican Pharmacy?

It’s illegal to personally import prescription drugs into the U.S. for personal use in most cases, even with a valid prescription. The FDA has discretion to allow personal imports for serious unmet medical needs but does not formally permit Wegovy imports.

How Long Does the Typical Resolution Date Take to Actually Mean Restocked Shelves?

About 4 to 8 weeks after the manufacturer’s “resolution date” hits, pharmacy-level supply normalizes. Wholesalers receive first, then chains, then independents, then mail-order catches up.

Does TrimRx Help with Wegovy Specifically?

TrimRx focuses on compounded semaglutide and tirzepatide. We don’t dispense brand-name Wegovy. If you’re set on the brand product, NovoCare or a traditional pharmacy plus insurance is your path. If a personalized compounded option fits your clinical situation, our medical team can review.

Will Wegovy Stay on the Resolved List Through 2026?

Most analyst forecasts say yes, with intermittent strength-level gaps. Novo Nordisk’s expanded capacity should support U.S. demand barring another indication expansion or competing product disruption.

Is the 0.25 Mg Starter Dose Ever in Shortage?

Rarely. Novo Nordisk explicitly prioritizes titration strengths to keep new patient starts flowing. If you’re hearing 0.25 mg is unavailable, call another pharmacy.

What’s the Fastest Way to Know If My Prescription Will Fill Today?

Call the pharmacy and ask: “Do you have Wegovy 1.7 mg (or your dose) in stock right now, and how many pens?” Numbers matter. “Yes” sometimes means one pen reserved for another patient.

Disclaimer: This content is for informational purposes only and does not constitute medical advice. It is not intended to diagnose, treat, cure, or prevent any disease or condition. Individual results may vary. Always consult a qualified healthcare professional before starting any weight loss program or medication.